Badalzadeh’s team found that STEMI patients with DM have a higher risk of IRI, which may be due to the combined effects of changes of glucose and lipid energy metabolism based on insulin resistance, enhanced oxidative stress and systemic inflammatory responses and ion channel dysfunction (13). The gene discussed is INS; the disease is diabetes mellitus.